Barry A. Morgan

3.3k total citations
32 papers, 1.7k citations indexed

About

Barry A. Morgan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Barry A. Morgan has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in Barry A. Morgan's work include Chemical Synthesis and Analysis (10 papers), Neuropeptides and Animal Physiology (7 papers) and Peptidase Inhibition and Analysis (6 papers). Barry A. Morgan is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Neuropeptides and Animal Physiology (7 papers) and Peptidase Inhibition and Analysis (6 papers). Barry A. Morgan collaborates with scholars based in United States, France and Switzerland. Barry A. Morgan's co-authors include Michael J. Rance, Colin F. C. Smith, B.K. Handa, John A.H. Lord, Anthony C. Lane, Terry Smith, Linda A. Fothergill, John Hughes, Jasbir Singh and Philip E. Hansen and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Barry A. Morgan

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry A. Morgan United States 19 1.3k 1.0k 305 262 204 32 1.7k
M. Chorev United States 27 1.4k 1.1× 779 0.8× 186 0.6× 166 0.6× 368 1.8× 56 2.0k
S. Bajusz Hungary 24 1.2k 0.9× 877 0.9× 300 1.0× 200 0.8× 226 1.1× 84 1.9k
Ulla E. Petäjä‐Repo Finland 24 1.7k 1.4× 883 0.9× 216 0.7× 60 0.2× 139 0.7× 50 2.4k
Anders Undén Sweden 19 917 0.7× 685 0.7× 66 0.2× 269 1.0× 97 0.5× 53 1.3k
Donald Yamashiro United States 25 1.7k 1.3× 906 0.9× 154 0.5× 379 1.4× 89 0.4× 86 2.0k
Victor J. Hruby United States 17 1.1k 0.8× 874 0.9× 217 0.7× 159 0.6× 125 0.6× 33 1.4k
Philip E. Brandish United States 17 1.1k 0.9× 308 0.3× 490 1.6× 191 0.7× 243 1.2× 31 1.9k
Simon Lemaire Canada 25 1.1k 0.9× 1.0k 1.0× 328 1.1× 95 0.4× 69 0.3× 77 1.7k
S. Blumberg Israel 16 662 0.5× 565 0.6× 202 0.7× 83 0.3× 312 1.5× 23 1.2k
Chinh Bach United States 12 707 0.6× 440 0.4× 143 0.5× 148 0.6× 91 0.4× 14 1.4k

Countries citing papers authored by Barry A. Morgan

Since Specialization
Citations

This map shows the geographic impact of Barry A. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Morgan more than expected).

Fields of papers citing papers by Barry A. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry A. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Morgan. The network helps show where Barry A. Morgan may publish in the future.

Co-authorship network of co-authors of Barry A. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Barry A. Morgan. A scholar is included among the top collaborators of Barry A. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry A. Morgan. Barry A. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kölmel, Dominik K., Hongyao Zhu, Mark E. Flanagan, et al.. (2021). Employing Photocatalysis for the Design and Preparation of DNA‐Encoded Libraries: A Case Study. The Chemical Record. 21(4). 616–630. 12 indexed citations
2.
Ding, Yun, Svetlana Belyanskaya, Jennifer L. DeLorey, et al.. (2021). Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT). Bioorganic & Medicinal Chemistry. 41. 116216–116216. 26 indexed citations
3.
Arico-Muendel, Christopher C., Bruce Belanger, Dennis R. Benjamin, et al.. (2013). Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity. Drug Metabolism and Disposition. 41(4). 814–826. 9 indexed citations
4.
Arico-Muendel, Christopher C., Dennis R. Benjamin, Paolo A. Centrella, et al.. (2013). Orally Active Fumagillin Analogues: Transformations of a Reactive Warhead in the Gastric Environment. ACS Medicinal Chemistry Letters. 4(4). 381–386. 7 indexed citations
5.
Deng, Hongfeng, et al.. (2013). Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. ACS Medicinal Chemistry Letters. 4(10). 942–947. 17 indexed citations
6.
Evindar, Ghotas, et al.. (2012). Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. Bioorganic & Medicinal Chemistry Letters. 23(2). 472–475. 2 indexed citations
7.
Evindar, Ghotas, Sylvie G. Bernier, Malcolm J. Kavarana, et al.. (2010). Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists. Bioorganic & Medicinal Chemistry Letters. 20(8). 2520–2524. 5 indexed citations
8.
Arico-Muendel, Christopher C., Barry A. Morgan, Gary O’Donovan, et al.. (2009). Antiparasitic activities of novel, orally available fumagillin analogs. Bioorganic & Medicinal Chemistry Letters. 19(17). 5128–5131. 20 indexed citations
9.
Evindar, Ghotas, Alexander L. Satz, Sylvie G. Bernier, et al.. (2009). Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists. Bioorganic & Medicinal Chemistry Letters. 19(8). 2315–2319. 6 indexed citations
10.
Evindar, Ghotas, Sylvie G. Bernier, Malcolm J. Kavarana, et al.. (2008). Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists. Bioorganic & Medicinal Chemistry Letters. 19(2). 369–372. 11 indexed citations
11.
Hu, Yongbo, et al.. (2002). Rapid Determination of Substrate Specificity of Clostridium histolyticum β-Collagenase Using an Immobilized Peptide Library. Journal of Biological Chemistry. 277(10). 8366–8371. 23 indexed citations
12.
Prévost, Grégoire, Anne Pradines, Marie-Christine Brézak, et al.. (2001). Inhibition of human tumor cell growthin vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228. International Journal of Cancer. 91(5). 718–722. 23 indexed citations
13.
Contour-Galcéra, Marie-Odile, et al.. (2001). Novel non-peptide ligands for the somatostatin sst3 receptor. Bioorganic & Medicinal Chemistry Letters. 11(8). 991–995. 12 indexed citations
14.
Rueter, Jaimie K., Ralph–Heiko Mattern, Lı Zhang, et al.. (2000). Syntheses and biological activities of sandostatin analogs containing stereochemical changes in positions 6 or 8. Biopolymers. 53(6). 497–505. 4 indexed citations
15.
Tran, Thuy-Anh, Ralph–Heiko Mattern, Barry A. Morgan, John E. Taylor, & Murray Goodman. (1999). Synthesis and binding potencies of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues. Journal of Peptide Science. 5(3). 113–130. 7 indexed citations
16.
Pradines, Anne, Isabelle Viossat, Marie-Christine Brézak, et al.. (1999). Inhibition of human tumor cell growthIn vitro andIn vivo by a specific inhibitor of human farnesyltransferase: BIM-46068. International Journal of Cancer. 83(2). 283–287. 15 indexed citations
17.
Hocart, Simon J., Rahul Jain, William A. Murphy, et al.. (1998). Potent Antagonists of Somatostatin:  Synthesis and Biology. Journal of Medicinal Chemistry. 41(7). 1146–1154. 47 indexed citations
18.
Singh, Jasbir, et al.. (1993). An efficient synthesis and acylation of α-amino-β-keto-esters: Versatile intermediates in the synthesis of peptide mimetics.. Tetrahedron Letters. 34(2). 211–214. 33 indexed citations
19.
Hansen, Philip E., et al.. (1993). Peptide azoles: A new class of biologically-active dipeptide mmetics.. Bioorganic & Medicinal Chemistry Letters. 3(5). 915–920. 29 indexed citations
20.
Hassall, Cedric H. & Barry A. Morgan. (1973). Tetracycline studies. Part IV. Some novel cyclisations through benzophenone carbanions, including a new synthesis of anthraquinones. Journal of the Chemical Society Perkin Transactions 1. 2853–2853. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Chorev Breakdown of academic impact, for papers by S. Bajusz Breakdown of academic impact, for papers by Ulla E. Petäjä‐Repo Breakdown of academic impact, for papers by Anders Undén Breakdown of academic impact, for papers by Donald Yamashiro Breakdown of academic impact, for papers by Victor J. Hruby Breakdown of academic impact, for papers by Philip E. Brandish Breakdown of academic impact, for papers by Simon Lemaire Breakdown of academic impact, for papers by S. Blumberg Breakdown of academic impact, for papers by Chinh Bach
Rankless by CCL
2026